NCT04983199

Patient Reported Outcomes/Metrics Program Trial

Patient Reported Outcomes/Metrics Program Trial - Palliative Radiation

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: University Health Network, Toronto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an observational study to investigate if it is feasible to recruit 100 patients receiving radiotherapy (RT) to metastatic disease to wear Hexoskin and if Hexoskin will facilitate the monitoring, detection and early treatment of RT-related side effects.

Detailed description

Radiotherapy is an important adjunct in the interdisciplinary care of the palliative patient population, providing the potential for improved quality of life and symptom control, often translating into improved well-being, function and mobility. Changes in pain and QOL are frequently measured subjectively using patient-reported questionnaires. Objective measures such as respiratory rate, pulse rate, activity level and sleep duration and quality, may complement the currently available tools. Such tools may lead to better evaluation of the effects of palliative RT with real-time detection of potential complications and toxicity and the acute need for analgesic adjustments that can result from successful palliative RT.

Conditions

• Metastatic Cancer
• Palliative

Interventions

Type	Name	Description
DEVICE	Hexoskin Medical System	Hexoskin is a smart shirt that can detect heart rates, lung function and physical activity of patients before and after radiotherapy.

Timeline

• Start date: 2022-11-24
• Primary completion: 2027-09-01
• Completion: 2027-09-01
• First posted: 2021-07-30
• Last updated: 2026-03-05

Locations

1 site across 1 country: Canada